AGO2 and metastatic malignant neoplasm: CAV-1-AGO2 interactions in the plasma membrane also trigger the sorting and secretion of miR-3613-3p-AGO2-RISC in extracellular vesicles (EVs) in the plasma of metastatic cancer patients [103].